A case of polymyalgia rheumatica complicated with giant thoracic aortic aneurysm with massive intraluminal thrombosis
Yuta Sakai
Division of Geriatric and Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Search for more papers by this authorCorresponding Author
Atsuhiro Kanno
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Correspondence
Atsuhiro Kanno MD PhD, Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, 2-29-1 Yamatomachi, Wakabayasi, Sendai, Miyagi 984-8560 Japan.
Email: [email protected]
Search for more papers by this authorYoshiaki Sato
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorTakehito Ito
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorKeiji Matsumoto
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorMasamichi Ueno
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorKazuhiro Sumitomo
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorKatsutoshi Furukawa
Division of Geriatric and Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Search for more papers by this authorYuta Sakai
Division of Geriatric and Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Search for more papers by this authorCorresponding Author
Atsuhiro Kanno
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Correspondence
Atsuhiro Kanno MD PhD, Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, 2-29-1 Yamatomachi, Wakabayasi, Sendai, Miyagi 984-8560 Japan.
Email: [email protected]
Search for more papers by this authorYoshiaki Sato
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorTakehito Ito
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorKeiji Matsumoto
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorMasamichi Ueno
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorKazuhiro Sumitomo
Department of General Medicine, Tohoku Medical and Pharmaceutical University, Wakabayashi Hospital, Sendai, Japan
Search for more papers by this authorKatsutoshi Furukawa
Division of Geriatric and Community Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan
Search for more papers by this authorOpen Research
Data availability statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
References
- 1Okura T, Kitami Y, Takata Y, Fukuoka T, Arimitsu J, Hiwada K. Giant unruptured aneurysm of the thoracic aorta–a case report. Angiology 1999; 50: 865–869. https://doi.org/10.1177/000331979905001012.
- 2Meyermann K, Trani J, Caputo FJ, Lombardi JV. Descending thoracic aortic mural thrombus presentation and treatment strategies. J Vasc Surg 2017; 66: 931–936. https://doi.org/10.1016/j.jvs.2017.05.109.
- 3Hiratzka LF, Bakris GL, Beckman JA et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation 2010; 121: e266–e369. https://doi.org/10.1161/CIR.0b013e3181d4739e.
- 4Kebed DT, Bois JP, Connolly HM et al. Spectrum of aortic disease in the Giant cell arteritis population. Am J Cardiol 2018; 121: 501–508. https://doi.org/10.1016/j.amjcard.2017.11.011.
- 5Evans J, Hunder GG. The implications of recognizing large-vessel involvement in elderly patients with giant cell arteritis. Curr Opin Rheumatol 2017; 9: 37–40. https://doi.org/10.1097/00002281-199701000-00007.
10.1097/00002281-199701000-00007 Google Scholar
- 6Boyd AJ. Intraluminal thrombus: innocent bystander or factor in abdominal aortic aneurysm pathogenesis? JVS Vasc Sci 2021; 2: 159–169. https://doi.org/10.1016/j.jvssci.2021.02.001.
- 7Bluestein D, Dumont K, de Beule M et al. Intraluminal thrombus and risk of rupture in patient specific abdominal aortic aneurysm-FSI modelling. Comput Methods Biomech Biomed Engin 2009; 12: 73–81. https://doi.org/10.1080/10255840903077170.
- 8Ma X, Xia S, Liu G, Song C. The detrimental role of intraluminal thrombus outweighs protective advantage in abdominal aortic aneurysm pathogenesis: the implications for the anti-platelet therapy. Biomolecules 2022; 12: 942. https://doi.org/10.3390/biom12070942.
